Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.670 | strong | 1.000 | 12 | 19 | 2000 | 2010 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.600 | strong | 1.000 | 5 | 1 | 2000 | 2009 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.510 | None | 1.000 | 2 | 0 | 1995 | 1998 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.500 | None | 1.000 | 12 | 2 | 1991 | 2014 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 0.990 | 103 | 0 | 2004 | 2020 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 0.989 | 93 | 0 | 2005 | 2020 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 1.000 | 29 | 0 | 1995 | 2017 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 0.929 | 14 | 1 | 2006 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 1.000 | 13 | 2 | 2001 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 1.000 | 13 | 2 | 2001 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.390 | None | 1.000 | 11 | 3 | 2007 | 2020 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 2007 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.310 | None | 1.000 | 3 | 0 | 2005 | 2013 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.310 | None | 1.000 | 3 | 0 | 2005 | 2012 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2005 | 2011 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2012 | 2017 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.310 | None | 0.500 | 1 | 0 | 2009 | 2011 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2005 | 2011 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2005 | 2011 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.300 | None | 0 | 0 |